MedWatch

Medicines Council chairman looks back after two years: "We had experiences we did not prepare for"

After two years, an external body is now to evaluate whether the Danish Medicines Council serves its purpose and its political working conditions. According to co-chairman, the council has made a good start despite challenges on the way.

Jørgen Schøler Kristensen shares the chairmanship in the Medicines Council with Steen Werner Hansen. | Foto: Henning Bagger/Ritzau Scanpix

Objectivity policy, the Spinraza case, political cross pressure and the arm's length principle. 12 week-deadlines, the principle of openness and intense media attention.

These are the various challenges the Danish Medicines Council has had to face during its short time of existence.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier